BioSpace News Archive

TB12, the health and wellness brand co-founded by six-time Super Bowl champion Tom Brady and business partner Alex Guerrero, announces today the launch of Protect, an immunity blend supplement made from clinically studied ingredients.

Bayer Fund, a philanthropic arm of life sciences company Bayer, today awarded more than $4 million in grants to 250 charities and non-profit organizations throughout the United States.

Kubota Vision Inc., a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., announced positive clinical results from myopia control tests in humans.

Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, announces today that ABX464 inhibits replication of SARS-CoV-2 in an in vitro reconstituted human respiratory epithelium model, as assessed by Transepithelial electrical resistance and RTqPCR.

The Jayne Koskinas Ted Giovanis Foundation for Health and Policy awarded initial funding to Paul Macklin, a mathematician and associate professor of Intelligent Systems Engineering at Indiana University, to support rapid, community-driven development of a SARS-COV-2 tissue simulator.

Blue Earth Diagnostics Announces Results from Early Clinical Experience with Targeted PET Imaging Agent rhPSMA-7.3 ( 18 F) in Men with Intermediate and High-risk Prostate Cancer − Results related to Company’s investigational Phase 3 radiohybrid PSMA agent presented at the AUA2020 Virtual Meeting − BURLINGTON, Mass. & OXFORD, England--( BUSINESS WIRE )-- Blue Earth Diagnostics, a Bracco company focused on molecular imaging diagnostics, today announc

Preliminary data from NantKwest collaborators suggests mesenchymal stem cell treatments may benefit COVID-19 patients with acute respiratory distress syndrome and cytokine storm Trial anticipated to initiate in Los Angeles area hospitals in Q2 Proprietary automated “GMP-in-a-Box”, an in-house manufacturing apparatus, enables rapidly scalable, off-the-shelf allogeneic mesenchymal stem cell product BM-Allo.MSC EL SEGUNDO, Calif.--

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the successful implementation of its Rapid Restart™ program. Launched over a month ago, Taconic was the first animal model provider in the industry to provide researchers with a program specifically designed to aid laboratories transitioning back to increased productivity. COVID-19 forced many institutions to discontinue critical research prog

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to deliver oxygen to the areas where it is needed most, today announced that it has entered into definitive securities purchase agreements with certain institutional and accredited investors to purchase, in a registered direct o

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that it has initiated a Phase 1b /2 clinical study in patients undergoing bunionectomy of HTX-034, Hero